Pancreatic Hormones Response-Generated Machine Learning Model Help Distinguish Sporadic Pancreatic Cancer From New-Onset Diabetes Cohort

被引:0
|
作者
Bao, Jiantong [1 ]
Li, Ling [1 ]
Sun, Chenyu [2 ]
Qi, Liang [1 ]
Tuason, John Pocholo W. [2 ]
Kim, Na Hyun [2 ]
Bhan, Chandur [2 ]
Abdul, Humaed Mohammed [2 ]
机构
[1] Southeast Univ, Sch Med, Zhongda Hosp, Nanjing, Jiangsu, Peoples R China
[2] AMITA Hlth St Joseph Hosp, Chicago, IL USA
来源
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
S88
引用
收藏
页码:S38 / S38
页数:1
相关论文
共 50 条
  • [41] Usefulness of CA 19–9 for pancreatic cancer screening in patients with new-onset diabetes
    Jung Wan Choe
    Hyo Jung Kim
    Jae Seon Kim
    Jaehyung Cha
    Moon Kyung Joo
    Beom Jae Lee
    Jong-Jae Park
    Young-Tae Bak
    Hepatobiliary&PancreaticDiseasesInternational, 2018, 17 (03) : 263 - 268
  • [42] Predicting the risk of pancreatic cancer in patients with new-onset diabetes based on CT image
    Zhou, Yu
    Yang, Jiabin
    Zeng, Liangtang
    Wu, Lei
    Wu, Zhuo
    Liu, Si-Yang
    Zheng, Shangyou
    Chen, Changhao
    Chen, Rufu
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [43] Risk Factors for Pancreatic Cancer in New-Onset Diabetes Mellitus: A Population Based Study
    Mansoor, Emad
    Parikh, Keyur P.
    Kim, Chang H.
    Glessing, Brooke
    Chak, Amitabh
    Cooper, Gregory S.
    GASTROENTEROLOGY, 2016, 150 (04) : S233 - S233
  • [44] Impacts of new-onset and long-term diabetes on clinical outcome of pancreatic cancer
    Li, Donghui
    Mao, Yixiang
    Chang, Ping
    Liu, Chang
    Hassan, Manal M.
    Yeung, Saiching J.
    Abbruzzese, James L.
    AMERICAN JOURNAL OF CANCER RESEARCH, 2015, 5 (10): : 3260 - 3269
  • [45] A Reduced Pancreatic Polypeptide Response is Associated With New-onset Pancreatogenic Diabetes Versus Type 2 Diabetes
    Hart, Phil A.
    Kudva, Yogish C.
    Yadav, Dhiraj
    Andersen, Dana K.
    Li, Yisheng
    Toledo, Frederico G. S.
    Wang, Fuchenchu
    Bellin, Melena D.
    Bradley, David
    Brand, Randall E.
    Cusi, Kenneth
    Fisher, William
    Mather, Kieren
    Park, Walter G.
    Saeed, Zeb
    Considine, Robert V.
    Graham, Sarah C.
    Rinaudo, Jo Ann
    Serrano, Jose
    Goodarzi, Mark O.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2023, 108 (05): : E120 - E128
  • [46] Predicting Pancreatic Cancer in New-Onset Diabetes Cohort Using a Novel Model With Integrated Clinical and Genetic Indicators: A Large-Scale Prospective Cohort Study
    Sun, Yongji
    Hu, Chaowen
    Hu, Sien
    Xu, Hongxia
    Gong, Jiali
    Wu, Yixuan
    Fan, Yiqun
    Lv, Changming
    Song, Tianyu
    Lou, Jianyao
    Zhang, Kai
    Wu, Jian
    Li, Xiawei
    Wu, Yulian
    CANCER MEDICINE, 2024, 13 (21):
  • [47] New-onset type 2 diabetes mellitus - A high-risk the screening of pancreatic cancer? group suitable for the screening of pancreatic cancer?
    Illes, Dora
    Terzin, Viktoria
    Holzinger, Gabor
    Kosar, Klara
    Roka, Richard
    Zsori, Gabor
    Abraham, Gyoergy
    Czako, Laszlo
    PANCREATOLOGY, 2016, 16 (02) : 266 - 271
  • [48] Exocrine Pancreatic Dysfunction Increases the Risk of New-Onset Diabetes Mellitus: Results of a Nationwide Cohort Study
    Cho, Jaelim
    Scragg, Robert
    Pandol, Stephen J.
    Petrov, Maxim S.
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2021, 14 (01): : 170 - 178
  • [49] New-onset Diabetes Mellitus as a Potential Initial Marker of Resectable Pancreatic Cancer: Data From EUS Registry
    Singh, J.
    Parikh, D. A.
    Urayama, S.
    PANCREAS, 2014, 43 (08) : 1408 - 1409
  • [50] New-Onset Diabetes, Longitudinal Trends in Metabolic Markers, and Risk of Pancreatic Cancer in a Heterogeneous Population
    Huang, Brian Z.
    Pandol, Stephen J.
    Jeon, Christie Y.
    Chari, Suresh T.
    Sugar, Catherine A.
    Chao, Chun R.
    Zhang, Zuo-Feng
    Wu, Bechien U.
    Setiawan, Veronica Wendy
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2020, 18 (08) : 1812 - +